Tesamorelin is produced in a lab to work like a hormone already present in the body.
A hormone is a chemical message. Tesamorelin signals the release of the body’s own growth hormone.
Understand the medicine and its use
Peptides are chains of building blocks also used to make proteins.
That word describes the chain. For a care decision, get the medicine’s name and ask why it is being proposed.
What taking it involves
The tesamorelin labels checked on September 28, 2026, describe a daily injection under the skin of the belly.
Ask who will show you how to use the exact product, explain storage and supplies, and help if the routine is hard to manage.
Look for the whole product name
As of September 28, 2026, the approved tesamorelin labels name EGRIFTA SV and EGRIFTA WR.
The label says these forms cannot be swapped for each other.
At a visit, ask for the name to be written down. If the answer is just “tesamorelin,” ask which product that means.
Read the source notes
Source-check dates: September 26, 2026 / September 28, 2026.
Ask for confirmation of the current product, rules and costs before deciding on care.